InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

OneMedNet Corp

ONMD Clue Score47
United Kingdom Fiscal year ends December CIK 0001849380
$4.30 -10.79% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.30 −57.21% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 24 Jun 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2022Revenue1.2Operating income−7.7Net income−30.5EPS, diluted−7.66Fiscal year 2023Revenue1.0 −11.4%Operating income−6.9Net income−33.8EPS, diluted−4.65Fiscal year 2024Revenue0.6 −37.0%Operating income−9.6Net income−10.1EPS, diluted−0.36Fiscal year 2025Revenue1.4 +111.4%Operating income−9.7Net income−2.8EPS, diluted−0.06
FY2022FY2023FY2024FY2025
Revenue 1.2 1.0 0.6 1.4
Growth −11.4% −37.0% +111.4%
Operating income −7.7 −6.9 −9.6 −9.7
Net income −30.5 −33.8 −10.1 −2.8
Growth
EPS, diluted −7.66 −4.65 −0.36 −0.06

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2022Gross margin−31.2%Operating margin−669.1%Net margin−2,641.0%Free cash flow margin−412.9%Fiscal year 2023Gross margin−12.6%Operating margin−671.2%Net margin−3,308.5%Free cash flow margin−473.6%Fiscal year 2024Gross margin−43.7%Operating margin−1,493.8%Net margin−1,575.3%Free cash flow margin−1,089.1%Fiscal year 2025Gross margin−37.0%Operating margin−711.3%Net margin−206.1%Free cash flow margin−553.1%
FY2022FY2023FY2024FY2025
Gross margin −31.2% −12.6% −43.7% −37.0%
Operating margin −669.1% −671.2% −1,493.8% −711.3%
Net margin −2,641.0% −3,308.5% −1,575.3% −206.1%
Free cash flow margin −412.9% −473.6% −1,089.1% −553.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−4.7Capital expenditure−0.1Free cash flow−4.8Fiscal year 2023Operating cash flow−4.8Capital expenditure−0.0Free cash flow−4.8Fiscal year 2024Operating cash flow−7.0Capital expenditure−0.1Free cash flow−7.0Fiscal year 2025Operating cash flow−7.5Capital expenditure−0.0Free cash flow−7.5
FY2022FY2023FY2024FY2025
Operating cash flow −4.7 −4.8 −7.0 −7.5
Capital expenditure −0.1 −0.0 −0.1 −0.0
Free cash flow −4.8 −4.8 −7.0 −7.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2022Cash0.3Shareholders’ equity−26.4Fiscal year 2023Cash0.0Total debt0.5Net cash (debt)−0.4Shareholders’ equity−13.4Fiscal year 2024Cash0.2Total debt2.3Net cash (debt)−2.1Shareholders’ equity−16.0Fiscal year 2025Cash0.6Total debt0.2Net cash (debt)0.4Shareholders’ equity−3.0
FY2022FY2023FY2024FY2025
Cash 0.3 0.0 0.2 0.6
Total debt n/a 0.5 2.3 0.2
Net cash (debt) n/a −0.4 −2.1 0.4
Shareholders’ equity −26.4 −13.4 −16.0 −3.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−31.2% −12.6% −43.7% −37.0%
−669.1% −671.2% −1,493.8% −711.3%
−2,639.5% −3,306.8% −1,575.0% −206.0%
−2,641.0% −3,308.5% −1,575.3% −206.1%
−412.9% −473.6% −1,089.1% −553.1%
Spending
138.0% 202.3% 228.1% 111.5%
416.8% 347.1% 1,092.8% 469.2%
5.0% 4.3% 7.9% 1.0%
Returns
−2,362.4% −7,280.2% −271.8% −130.2%
Balance and payout
2,144.9% 2,997.0% 528.0% 237.8%